Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H18O3S |
Molecular Weight | 278.367 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC1=CC(=C2C=C(C=CC=C12)C(C)C)S(O)(=O)=O
InChI
InChIKey=NARQSHREEUXZBT-UHFFFAOYSA-N
InChI=1S/C15H18O3S/c1-4-11-9-15(19(16,17)18)14-8-12(10(2)3)6-5-7-13(11)14/h5-10H,4H2,1-3H3,(H,16,17,18)
Molecular Formula | C15H18O3S |
Molecular Weight | 278.367 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/23568973
Sources: http://www.ncbi.nlm.nih.gov/pubmed/23568973
Egualen is an azulene derivative developed for the treatment of peptic ulcer and marketed in Japan under the tradename Azuloxa. The drug exerts its antiulcer activity by antagonizing TXA2 production.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0038193 Sources: http://www.ncbi.nlm.nih.gov/pubmed/23568973 |
|||
Target ID: GO:1990768 Sources: http://www.ncbi.nlm.nih.gov/pubmed/23568973 |
|||
Target ID: GO:0070254 Sources: http://www.ncbi.nlm.nih.gov/pubmed/23568973 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | AZULOXA Approved UseUnknown |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:30:27 GMT 2023
by
admin
on
Fri Dec 15 16:30:27 GMT 2023
|
Record UNII |
17VM9WN49U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29698
Created by
admin on Fri Dec 15 16:30:27 GMT 2023 , Edited by admin on Fri Dec 15 16:30:27 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
993
Created by
admin on Fri Dec 15 16:30:27 GMT 2023 , Edited by admin on Fri Dec 15 16:30:27 GMT 2023
|
PRIMARY | |||
|
DTXSID2052861
Created by
admin on Fri Dec 15 16:30:27 GMT 2023 , Edited by admin on Fri Dec 15 16:30:27 GMT 2023
|
PRIMARY | |||
|
17VM9WN49U
Created by
admin on Fri Dec 15 16:30:27 GMT 2023 , Edited by admin on Fri Dec 15 16:30:27 GMT 2023
|
PRIMARY | |||
|
99287-30-6
Created by
admin on Fri Dec 15 16:30:27 GMT 2023 , Edited by admin on Fri Dec 15 16:30:27 GMT 2023
|
PRIMARY | |||
|
85542
Created by
admin on Fri Dec 15 16:30:27 GMT 2023 , Edited by admin on Fri Dec 15 16:30:27 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105570
Created by
admin on Fri Dec 15 16:30:27 GMT 2023 , Edited by admin on Fri Dec 15 16:30:27 GMT 2023
|
PRIMARY | |||
|
100000080538
Created by
admin on Fri Dec 15 16:30:27 GMT 2023 , Edited by admin on Fri Dec 15 16:30:27 GMT 2023
|
PRIMARY | |||
|
C73186
Created by
admin on Fri Dec 15 16:30:27 GMT 2023 , Edited by admin on Fri Dec 15 16:30:27 GMT 2023
|
PRIMARY | |||
|
SUB06474MIG
Created by
admin on Fri Dec 15 16:30:27 GMT 2023 , Edited by admin on Fri Dec 15 16:30:27 GMT 2023
|
PRIMARY | |||
|
6823
Created by
admin on Fri Dec 15 16:30:27 GMT 2023 , Edited by admin on Fri Dec 15 16:30:27 GMT 2023
|
PRIMARY | |||
|
65858
Created by
admin on Fri Dec 15 16:30:27 GMT 2023 , Edited by admin on Fri Dec 15 16:30:27 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |